Emily Rizo
- Epidemiology top 2%
- Hepatology top 1%
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Physiology
- Co-authors
- Rohit LoombaClaude B. SirlinLisa RichardsRicki BettencourtCarolyn HernandezJonathan HookerEthan SyDavid A. Brenner
- Topics
- Liver Disease Diagnosis and Treatment (12 papers)Liver Diseases and Immunity (6 papers)Liver Disease and Transplantation (5 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Emily Rizo
12 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Epidemiology 1.3k
- Hepatology 847
- Endocrinology, Diabetes and Metabolism 314
- Molecular Biology 230
- Physiology 159
Countries citing papers authored by Emily Rizo
This map shows the geographic impact of Emily Rizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Rizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Rizo more than expected).
Fields of papers citing papers by Emily Rizo
This network shows the impact of papers produced by Emily Rizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Rizo. The network helps show where Emily Rizo may publish in the future.
Co-authorship network of co-authors of Emily Rizo
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Rizo. A scholar is included among the top collaborators of Emily Rizo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Rizo. Emily Rizo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 239 | |
| 3 | 60 | |
| 4 | 45 | |
| 5 | 113 | |
| 6 | 56 | |
| 7 | 16 | |
| 8 | Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisbreakdown → | 273 |
| 9 | 7 | |
| 10 | 31 | |
| 11 | 24 | |
| 12 | Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Diseasebreakdown → | 518 |
About Emily Rizo
Emily Rizo is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (6 papers) and Liver Disease and Transplantation (5 papers). The work is most often cited by research in Hepatology (847 citations), Epidemiology (1.3k citations) and Endocrinology, Diabetes and Metabolism (314 citations). Emily Rizo has collaborated with scholars based in United States and France. Frequent co-authors include Rohit Loomba, Claude B. Sirlin, Lisa Richards, Ricki Bettencourt, Carolyn Hernandez, Jonathan Hooker, Ethan Sy, David A. Brenner, Phirum Nguyen and Cyrielle Caussy. Their work appears in journals such as Nature Communications, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.